Cargando…

Influence of amount and percentage of CXCR4-using virus in predicting week 48 responses to maraviroc in treatment-naïve patients

Detalles Bibliográficos
Autores principales: Valdez, H, Chapman, D, Biswai, P, Lewis, M, Craig, C, Heera, J, Ellery, S, Swenson, LC, Harrigan, PR
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The International AIDS Society 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3112823/
http://dx.doi.org/10.1186/1758-2652-13-S4-O11
_version_ 1782205825376321536
author Valdez, H
Chapman, D
Biswai, P
Lewis, M
Craig, C
Heera, J
Ellery, S
Swenson, LC
Harrigan, PR
author_facet Valdez, H
Chapman, D
Biswai, P
Lewis, M
Craig, C
Heera, J
Ellery, S
Swenson, LC
Harrigan, PR
author_sort Valdez, H
collection PubMed
description
format Online
Article
Text
id pubmed-3112823
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher The International AIDS Society
record_format MEDLINE/PubMed
spelling pubmed-31128232011-06-13 Influence of amount and percentage of CXCR4-using virus in predicting week 48 responses to maraviroc in treatment-naïve patients Valdez, H Chapman, D Biswai, P Lewis, M Craig, C Heera, J Ellery, S Swenson, LC Harrigan, PR J Int AIDS Soc Oral Presentation The International AIDS Society 2010-11-08 /pmc/articles/PMC3112823/ http://dx.doi.org/10.1186/1758-2652-13-S4-O11 Text en Copyright ©2010 Valdez et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Oral Presentation
Valdez, H
Chapman, D
Biswai, P
Lewis, M
Craig, C
Heera, J
Ellery, S
Swenson, LC
Harrigan, PR
Influence of amount and percentage of CXCR4-using virus in predicting week 48 responses to maraviroc in treatment-naïve patients
title Influence of amount and percentage of CXCR4-using virus in predicting week 48 responses to maraviroc in treatment-naïve patients
title_full Influence of amount and percentage of CXCR4-using virus in predicting week 48 responses to maraviroc in treatment-naïve patients
title_fullStr Influence of amount and percentage of CXCR4-using virus in predicting week 48 responses to maraviroc in treatment-naïve patients
title_full_unstemmed Influence of amount and percentage of CXCR4-using virus in predicting week 48 responses to maraviroc in treatment-naïve patients
title_short Influence of amount and percentage of CXCR4-using virus in predicting week 48 responses to maraviroc in treatment-naïve patients
title_sort influence of amount and percentage of cxcr4-using virus in predicting week 48 responses to maraviroc in treatment-naïve patients
topic Oral Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3112823/
http://dx.doi.org/10.1186/1758-2652-13-S4-O11
work_keys_str_mv AT valdezh influenceofamountandpercentageofcxcr4usingvirusinpredictingweek48responsestomaravirocintreatmentnaivepatients
AT chapmand influenceofamountandpercentageofcxcr4usingvirusinpredictingweek48responsestomaravirocintreatmentnaivepatients
AT biswaip influenceofamountandpercentageofcxcr4usingvirusinpredictingweek48responsestomaravirocintreatmentnaivepatients
AT lewism influenceofamountandpercentageofcxcr4usingvirusinpredictingweek48responsestomaravirocintreatmentnaivepatients
AT craigc influenceofamountandpercentageofcxcr4usingvirusinpredictingweek48responsestomaravirocintreatmentnaivepatients
AT heeraj influenceofamountandpercentageofcxcr4usingvirusinpredictingweek48responsestomaravirocintreatmentnaivepatients
AT ellerys influenceofamountandpercentageofcxcr4usingvirusinpredictingweek48responsestomaravirocintreatmentnaivepatients
AT swensonlc influenceofamountandpercentageofcxcr4usingvirusinpredictingweek48responsestomaravirocintreatmentnaivepatients
AT harriganpr influenceofamountandpercentageofcxcr4usingvirusinpredictingweek48responsestomaravirocintreatmentnaivepatients